Hillhouse-Backed Biotech Firm Jacobio Plans Hong Kong IPO

Jacobio Pharmaceuticals Co., a Chinese biotechnology company focusing on cancer treatments, is planning a Hong Kong initial public offering as soon as this year, according to people familiar with the …
( read original story …)

---